EFFECTS OF CEFPIROME IN COMPARISON WITH CEFUROXIME AGAINST HUMAN POLYMORPHONUCLEAR LEUKOCYTES IN-VITRO

被引:12
|
作者
MORAN, FJ
PUENTE, LF
PEREZGIRALDO, C
HURTADO, C
BLANCO, MT
GOMEZGARCIA, AC
机构
[1] Department of Microbiology, Faculty of Medicine
关键词
D O I
10.1093/jac/33.1.57
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The interaction of cefpirome and cefuroxime, with human polymorphonuclear leucocytes (PMNs) was examined. The effects of therapeutic concentration (1, 10, and 50 mg/L) of both antimicrobial agents on the adherence, spontaneous mobility, chemotaxis, chemokinesis, phagocytosis and candidacidal capacity were studied in vitro. No statistically significant variations, in relation to the control, were observed in the ability of PMNs to adhere to nylon fibre at the concentrations of cefuroxime and cefpirome used. With both antimicrobial agents, PMN mobility increased as the antibiotic concentration was increased. A statistically significant increase (P < 0.05) in spontaneous mobility, chemotaxis and chemokinesis was observed with cefpirome at only 10 mg/L. However, only spontaneous mobility was increased significantly with cefuroxime at 10 mg/L. The strongest effects were observed with cefpirome at 50 mg/L with variations of about 70% (P < 0.01), in chemotaxis and chemokinesis. In general, cefpirome had a positive effect on phagocytosis and candidacidal power, which was significant at a concentration of 50 mg/L (P < 0.01). Cefuroxime, in general, produced no modifications in either phagocytosis or candidacidal power. © 1994 The British Society for Antimicrobial Chemotherapy.
引用
收藏
页码:57 / 62
页数:6
相关论文
共 50 条
  • [41] LYMPHOCYTE REACTIVITY IN-VITRO .7. EFFECT OF POLYMORPHONUCLEAR LEUKOCYTES ON LYMPHOCYTE RESPONSE
    BACH, ML
    BACH, FH
    WIDMER, M
    ORANEN, H
    WOLBERG, WH
    TRANSPLANTATION, 1971, 12 (04) : 283 - &
  • [42] Quantifying the Cytotoxicity of Staphyloccus aureus Against Human Polymorphonuclear Leukocytes
    Dankoff, Jennifer G.
    Pallister, Kyler B.
    Guerra, Fermin E.
    Parks, Alexander J.
    Gorham, Kelly
    Mastandrea, Saul
    Voyich, Jovanka M.
    Nygaard, Tyler K.
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2020, (155):
  • [43] A COMPARISON OF THE EFFECTS OF TOBRAMYCIN AND NETILMYCIN ON THE FUNCTIONS OF HUMAN POLYMORPHONUCLEAR LEUKOCYTES AND LYMPHOCYTES INVITRO AND INVIVO
    ANDERSON, R
    FERNANDES, AC
    EFTYCHIS, HA
    JOONE, G
    VANRENSBURG, AJ
    SOUTH AFRICAN MEDICAL JOURNAL, 1985, 67 (25): : 1007 - 1009
  • [44] IN-VITRO MODEL FOR ESTIMATING CHONDROMUCOPROTEIN DEGRADATION BY HUMAN POLYMORPHONUCLEAR LEUKOCYTES UTILIZING S-35 LABELED CARTILAGE
    ORONSKY, AL
    IGNARRO, LJ
    PERPER, RJ
    FEDERATION PROCEEDINGS, 1973, 32 (03) : 292 - &
  • [45] HUMAN IMMUNITY TO PSEUDOMONAS-AERUGINOSA .1. IN-VITRO INTERACTION OF BACTERIA, POLYMORPHONUCLEAR LEUKOCYTES, AND SERUM FACTORS
    YOUNG, LS
    ARMSTRONG, D
    JOURNAL OF INFECTIOUS DISEASES, 1972, 126 (03): : 257 - +
  • [46] Effects of glaucine on human isolated bronchus and human polymorphonuclear leukocytes
    Morcillo, EJ
    Cortijo, J
    Martí-Cabrera, M
    Villagrasa, V
    Berto, L
    Ortiz, JL
    Martinez-Losa, M
    BRITISH JOURNAL OF PHARMACOLOGY, 1998, 124 : U46 - U46
  • [47] LEUKOTRIENE-B(4) STIMULATES HUMAN POLYMORPHONUCLEAR LEUKOCYTES TO SYNTHESIZE AND RELEASE INTERLEUKIN-8 IN-VITRO
    MCCAIN, RW
    HOLDEN, EP
    BLACKWELL, TR
    CHRISTMAN, JW
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1994, 10 (06) : 651 - 657
  • [48] EFFECTS OF N-ACETYLCYSTEINE ON HUMAN POLYMORPHONUCLEAR LEUKOCYTES
    PAULSEN, O
    FORSGREN, A
    APMIS, 1989, 97 (02) : 115 - 119
  • [49] IN-VITRO ACTIVITY OF CEFPIROME AGAINST BETA-LACTAMASE-INDUCIBLE AND STABLY DEREPRESSED ENTEROBACTERIACEAE
    BONFIGLIO, G
    STEFANI, S
    NICOLETTI, G
    CHEMOTHERAPY, 1994, 40 (05) : 311 - 316
  • [50] ALTERATIONS OF THE OXIDATIVE-METABOLISM OF HUMAN POLYMORPHONUCLEAR LEUKOCYTES (PMNL) BY GOLD(I) AND GOLD(III) IN-VITRO AND INTERINDIVIDUAL DIFFERENCES AGAINST THE CYTOTOXICITY OF GOLD(I)
    BAGINSKI, B
    SCHUPPE, HC
    KIND, P
    GLEICHMANN, E
    AKTUELLE RHEUMATOLOGIE, 1994, 19 (01) : 27 - 32